1. Pharmaceuticals and Drug Development

Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of HAE

Written by Posted on Less than 0 min read

CARLSBAD, Calif., Nov. 4, 2024 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for donidalorsen, an investigational…

Member since

More from Admin

Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Alcohol consumption among non-human animals may not be as rare as previously thought, say ecologists

Anecdotes abound of wildlife behaving “drunk” after eating fermented fruits, but despite this, nonhuman consumption of ethanol has been assumed to be rare and accidental. Ecologists challenge this assumption in a review publishing October 30 in the Cell Press journal Trends in Ecology & Evolution. They argue that since ethanol is naturally present in nearly […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Study on architecture of heart offers new understanding of human evolution

An international research team from Swansea University and UBC Okanagan (UBCO) has uncovered a new insight into human evolution by comparing humans’ hearts with those of other great apes. Despite humans and non-human great apes having a common ancestor, the former has evolved larger brains and the ability to walk or run upright on two […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

When inequality is greater than ‘skin-deep’: Social standing leaves traces within the epigenome of noticed hyenas in Tanzania

A analysis consortium led by scientists from the Leibniz Institute for Zoo and Wildlife Analysis (Leibniz-IZW) present proof that social behaviour and social standing are mirrored on the molecular degree of gene activation (epigenome) in juvenile and grownup free-ranging noticed hyenas. They analysed non-invasively collected intestine epithelium samples from each high-ranking and low-ranking feminine hyenas […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Avian flu found in wastewater of 10 Texas cities through virome sequencing

Avian influenza A(H5N1) virus, which spread to cattle and infected 14 people this year, was detected using virome sequencing in the wastewater of 10 Texas cities by researchers at UTHealth Houston and Baylor College of Medicine. The virome is the collection of viruses in a sample, in this case a wastewater sample. The information was […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Microorganisms can travel long distances in the troposphere

Analysis of air samples taken at altitudes of up to 3,000 metres above Japan has revealed the presence of a vast range of viable bacteria and fungi transported by air masses originating more than 2,000 kilometres away, in regions enriched with fertilisers and pesticides. The study, published in Proceedings of the National Academy of Sciences […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Scientists uncover new way viruses fight back against bacteria

A microscopic discovery will not only enable scientists to understand the microbial world around us but could also provide a new way to control CRISPR-Cas biotechnologies. An international team of researchers led by Professor Peter Fineran from the University of Otago and Dr Rafael Pinilla-Redondo from the University of Copenhagen has published a study in […]
Written by
  1. Clinical

Prota Therapeutics Announces Publication in Allergy of Long-Term Peanut Allergy Study Confirming Clinical Remission as the Optimal Treatment Outcome

MELBOURNE, Australia, Aug. 14, 2024. Prota Therapeutics Pty Ltd (Prota), an Australian clinical-stage biotechnology company focused on the development of novel oral immunotherapy treatments that induce remission of allergy, today announced publication in the journal Allergy of the first long-term study directly comparing remission and desensitization endpoints following food allergen oral immunotherapy (OIT). The Phase […]
Written by
  1. Clinical

First Affected person Dosed in Section 2a Medical Trial of a First-in-Class Regenerative Cell Remedy for Sufferers with Finish-Stage Liver Illness

PITTSBURGH, April 2, 2024. LyGenesis, a clinical-stage biotechnology firm growing cell therapies for big unmet medical wants, introduced right this moment that the primary affected person has been dosed of their Section 2a scientific trial evaluating their first-in-class allogenic regenerative cell remedy transplanted into sufferers’ lymph nodes as a possible remedy for […]
Written by
  1. Clinical

Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia

OSAKA, Japan and CAMBRIDGE, Massachusetts, June 22, 2024 – Takeda (TSE:4502/NYSE:TAK) today presented positive results from its Phase 2b, randomized, double-blind, placebo-controlled study evaluating the safety, tolerability and efficacy of mezagitamab (TAK-079) in patients with persistent or chronic primary immune thrombocytopenia (ITP), a rare immune-mediated bleeding disorder. ITP is characterized by the accelerated destruction of […]
Written by
  1. Clinical

Getting Paid for Your Participation: Exploring Clinical Studies

Participating in clinical studies not only allows you to contribute to medical advancements but also gives you the opportunity to earn some extra cash. Clinical studies are essential for the development of new medicines, treatments, and therapies. These studies need individuals from various backgrounds who are willing to be part of the research process. If […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients

YANTAI, China, Nov. 15, 2023. RemeGen Co., Ltd. (“RemeGen” or “the Company”), a commercial-stage biotechnology company, is invited to present telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients in a Late-Breaking Abstract Oral Presentation Session by the American College of Rheumatology(RA). According to the abstract, this Phase III, randomized, double-blind study evaluated the […]
Written by
  1. Clinical

Avirmax Biopharma Inc. Receives IND Approval for Phase I/IIa Trial to Treat Wet AMD including PCV

HAYWARD, Calif., May 30, 2024. Avirmax Biopharma, Inc., a leading innovator in genetic medicines, is pleased to announce that it has received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) to initiate a Phase I/IIa clinical trial for its gene therapy treatment targeting wet Age-related Macular Degeneration (AMD) including Polypoidal […]
Written by
  1. Clinical

Harnessing the Power of Clinical Trials for Health and Wellness

Clinical trials play a crucial role in advancing health and wellness by harnessing the power of scientific research to develop innovative treatments, therapies, and preventive measures. These trials are carefully designed studies that evaluate the effectiveness and safety of new drugs, medical devices, diagnostic tools, or interventions. The primary goal of clinical trials is to […]
Written by
  1. Biology

City of Hope to offer second opinions for cancer patients in Southeast Asia

LOS ANGELES — Oncology specialists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, can now provide leading-edge clinical guidance to patients living in Southeast Asia through a second opinion collaboration agreement with the Healthway Cancer Care Hospital, the first comprehensive cancer hospital in […]
Written by
  1. Biology

Study by TU Graz shows that abrasion emissions from trains are not

In addition to exhaust emissions, abrasion emissions from tyres and brakes have become increasingly important when assessing the environmental impact of traffic. However, the focus here was on road vehicles; rail was hardly considered. In a study commissioned by the German Centre for Rail Transport Research (DZSF), researchers from the Institute of Thermodynamics and Sustainable […]
Written by
  1. Biology

Advanced biosensor uncovers role of gibberellin in integrating light

Advancements in biosensor technology are now letting us observe previously undetectable plant hormones orchestrating growth and responding to environmental stimuli in real-time within living plants. Credit: Alexander Jones research group, Sainsbury Laboratory, University of Cambridge Advancements in biosensor technology are now letting us observe previously undetectable plant hormones orchestrating growth and responding to environmental stimuli […]
Written by
  1. Biology

The new power for soft

In the dynamic landscape of intelligent technology, electrically powered artificial muscle fibers (EAMFs) are emerging as a revolutionary power source for advanced robotics and wearable devices. Renowned for their exceptional mechanical properties, integration flexibility, and functional versatility, EAMFs are at the forefront of cutting-edge innovation. A recent review article titled “Emerging Innovations in Electrically Powered […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Ixchiq (Chikungunya Vaccine, Live) for the Prevention of Disease Caused by Chikungunya Virus

FDA Approves Ixchiq (Chikungunya Vaccine, Live) for the Prevention of Disease Caused by Chikungunya Virus Saint-Herblain (France), November 10, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Administration (FDA) has approved Ixchiq®, Valneva’s single-dose, live-attenuated vaccine indicated for the prevention of disease […]
Written by
Next
No Comments
Leave a comment Cancel
Comments to: Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of HAE

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.